Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China’s Drug Quality Director Replaced In Tainted-Milk Scandal

This article was originally published in PharmAsia News

Executive Summary

The Chinese official in charge of supervising the quality of drugs and other products has resigned over the scandal involving infant fatalities related to tainted milk. Li Changjiang resigned as head of the General Administration of Quality Supervision, Inspection and Quarantine. Li became the highest-ranking official to lose his job over milk tainted with melamine, killing at least four babies and sickening more than 50,000 others. China's former deputy secretary-general of the Cabinet was named to replace Li as director of the quality agency. (Click here for more

The Chinese official in charge of supervising the quality of drugs and other products has resigned over the scandal involving infant fatalities related to tainted milk. Li Changjiang resigned as head of the General Administration of Quality Supervision, Inspection and Quarantine. Li became the highest-ranking official to lose his job over milk tainted with melamine, killing at least four babies and sickening more than 50,000 others. China's former deputy secretary-general of the Cabinet was named to replace Li as director of the quality agency. (Click here for more)

"Top Quality Supervisor Quits Over Milk Fiasco" - Shanghai Daily (China) (9/23/08)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel